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In Europe, increases in the incidence of influenza 
are observed in regular annual epidemics from autumn 
to spring. Severe illness and complications are more fre-
quent in certain risk groups, including children, persons 
with chronic medical conditions, and individuals aged 
65 years and over. The main public health intervention 
to prevent influenza is vaccination. In order to protect 
vulnerable individuals and to reduce transmission vac-
cination is also recommended for healthcare profes-
sionals.
According to the European Centre for Disease Pre-
vention and Control report “Seasonal influenza vacci-
nation in Europe – Vaccination recommendations and 
coverage rates for eight influenza seasons” [1], seasonal 
influenza vaccination coverage rates among Polish chil-
dren and adolescents did not exceed 4%. In the case of 
older age groups, a consensus was reached on an EU tar-
get of 75% vaccination coverage. So far, such coverage 
has only been reached in the Netherlands and the United 
Kingdom in some of the influenza seasons between 2008 
and 2015. In Poland, seasonal influenza vaccination 
coverage among the older population is stable but only 
slightly exceeds 10%.
The latest systematic review of the cost-effective-
ness of influenza immunisation found vaccination to 
be cost-effective for children, pregnant and postpartum 
women, high-risk groups, and, in some cases, healthy 
working-age adults [2]. Analysis conducted on data from 
Poland, including costs of hospitalisations and produc-
tivity loss, showed substantial possible economic savings 
for the Polish health care and social security system pro-
vided that the coverage rate was improved [3]. Increase 
in vaccination coverage would definitely be beneficial 
not only from a healthcare system perspective, but also 
on an individual level, by decreasing the probability of 
severe influenza and its complications in specific per-
sons. 
However, a considerable increase in vaccination cov-
erage in Poland is unlikely to occur very quickly. First 
of all, very limited social trust in influenza vaccination 
is observed. According to the European Commission’s 
report “State of vaccine confidence in the EU 2018” [4], 
it is even lower than the trust in MMR (measles, mumps, 
and rubella) vaccination. This, partially at least, may have 
resulted from seasonal differentiation in efficacy of the 
influenza vaccine (dependent on the change in its com-
position) but also from perceived underestimation of the 
risks associated with influenza in the general population. 
Another reason might be that influenza vaccination in 
Poland is not obligatory, financed by the vaccinee, and 
not reimbursable (except for some employee programs). 
It seems, however, that despite potential difficulties, 
results of economic analyses, such as the one presented 
in this issue of the JHI, should be seriously taken into 
account. They give a strong argument for the intensifica-
tion of actions aimed at increasing influenza vaccination 
coverage in Poland. Moreover, current low vaccination 
coverage and high seasonal influenza incidence rates, 
although unfavourable, provide a very good opportunity 
for substantial and noticeable improvement in this area 
and beneficial effects both on individual and population 
levels.
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